A retrospective study in intensive care patients found that metagenomic next-generation sequencing detected significantly more pathogens than conventional cultures, but showed low diagnostic specificity. The report highlights a practical tradeoff for clinical adoption: broader detection can create false positives that complicate antimicrobial decision-making. For sepsis workflows, the key next step is defining interpretation frameworks—distinguishing colonization from true infection—while improving assay performance for clinically actionable accuracy.
Get the Daily Brief